Works in European Journal of Nuclear Medicine & Molecular Imaging, 2024, Vol 51, Issue 5

Results: 37

Advances in targeted alpha therapy of cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1205, doi. 10.1007/s00259-024-06658-1

By:

Sathekge, Mike;
Morgenstern, Alfred

Publication type:

Article

Letter to the Editor: FDG Liver Biodistribution.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1213, doi. 10.1007/s00259-024-06652-7

By:

Bailey, Dale L.;
Schembri, Geoffrey P.;
Willowson, Kathy P.;
Roach, Paul J.

Publication type:

Article

Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1464, doi. 10.1007/s00259-024-06642-9

By:

Kabasakal, Levent;
Turkay, Ruştu;
Onal, Bulent

Publication type:

Article

EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1268, doi. 10.1007/s00259-024-06640-x

By:

Stokke, Caroline;
Gnesin, Silvano;
Tran-Gia, Johannes;
Cicone, Francesco;
Holm, Søren;
Cremonesi, Marta;
Blakkisrud, Johan;
Wendler, Thomas;
Gillings, Nic;
Herrmann, Ken;
Mottaghy, Felix M.;
Gear, Jonathan

Publication type:

Article

A. Zaheer, S.P. Raman, M.L. Rosado-de-Christenson, S. Martínez-Jiménez, S.H. Garrana, G. Fananapazir, D. Rogers, B.R. Foster: Imaging Anatomy: Chest, Abdomen, Pelvis, 3rd Edition: Elsevier, 2024, ISBN 9780443118005.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1201, doi. 10.1007/s00259-024-06607-y

By:

Mansi, Luigi

Publication type:

Article

Impact of patient motion on parametric PET imaging.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1493, doi. 10.1007/s00259-024-06599-9

By:

Artesani, Alessia;
van Sluis, Joyce;
van Snick, Johannes H.;
Providência, Laura;
Noordzij, Walter;
Tsoumpas, Charalampos

Publication type:

Article

Beyond stillness: the importance of tackling patient's motion for reliable parametric imaging.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1210, doi. 10.1007/s00259-024-06592-2

By:

Artesani, Alessia;
Providência, Laura;
van Sluis, Joyce;
Tsoumpas, Charalampos

Publication type:

Article

Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1421, doi. 10.1007/s00259-024-06591-3

By:

Ninatti, Gaia;
Moresco, Rosa Maria;
Sollini, Martina

Publication type:

Article

Correction to: Theranostic role of 89Zr‑ and 177Lu‑labeled aflibercept in breast cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1495, doi. 10.1007/s00259-023-06590-w

By:

Yang, Qi;
Chen, Zhao;
Qiu, Yongkang;
Huang, Wenpeng;
Wang, Tianyao;
Song, Lele;
Sun, Xinyao;
Li, Cuicui;
Xu, Xiaojie;
Kang, Lei

Publication type:

Article

After one year of ChatGPT's launch: reflections on artificial intelligence in scientific writing.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1203, doi. 10.1007/s00259-023-06579-5

By:

Feng, Yuan;
Han, Jinquan;
Lan, Xiaoli

Publication type:

Article

Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive l-[methyl-11C] methionine cohort study with two PET scanners.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1423, doi. 10.1007/s00259-023-06562-0

By:

Zhou, Weiyan;
Wen, Jianbo;
Huang, Qi;
Zeng, Yan;
Zhou, Zhirui;
Zhu, Yuhua;
Chen, Lei;
Guan, Yihui;
Xie, Fang;
Zhuang, Dongxiao;
Hua, Tao

Publication type:

Article

Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration-resistant prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1207, doi. 10.1007/s00259-023-06574-w

By:

Volpe, Fabio;
Piscopo, Leandra;
Zampella, Emilia;
Klain, Michele

Publication type:

Article

Expanding the clinical indications of [18F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1345, doi. 10.1007/s00259-023-06573-x

By:

Treglia, Giorgio;
Rizzo, Alessio;
Piccardo, Arnoldo

Publication type:

Article

Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1333, doi. 10.1007/s00259-023-06566-w

By:

Budenkotte, Thomas;
Apostolova, Ivayla;
Opfer, Roland;
Krüger, Julia;
Klutmann, Susanne;
Buchert, Ralph

Publication type:

Article

Effects of medication on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1323, doi. 10.1007/s00259-023-06565-x

By:

Piatkova, Yuliya;
Doyen, Matthieu;
Heyer, Sébastien;
Tahmazov, Ayaz;
Frismand, Solene;
Hopes, Lucie;
Imbert, Laetitia;
Verger, Antoine

Publication type:

Article

Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1246, doi. 10.1007/s00259-023-06575-9

By:

Yang, Qi;
Chen, Zhao;
Qiu, Yongkang;
Huang, Wenpeng;
Wang, Tianyao;
Song, Lele;
Sun, Xinyao;
Li, Cuicui;
Xu, Xiaojie;
Kang, Lei

Publication type:

Article

[177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1221, doi. 10.1007/s00259-023-06561-1

By:

Zeng, Ziqing;
Li, Liqiang;
Tao, Jinping;
Liu, Jiayue;
Li, Hongjun;
Qian, Xueming;
Yang, Zhi;
Zhu, Hua

Publication type:

Article

Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1395, doi. 10.1007/s00259-023-06559-9

By:

Li, Mengshi;
Robles-Planells, Claudia;
Liu, Dijie;
Graves, Stephen A.;
Vasquez-Martinez, Gabriela;
Mayoral-Andrade, Gabriel;
Lee, Dongyoul;
Rastogi, Prerna;
Marks, Brenna M.;
Sagastume, Edwin A.;
Weiss, Robert M.;
Linn-Peirano, Sarah C.;
Johnson, Frances L.;
Schultz, Michael K.;
Zepeda-Orozco, Diana

Publication type:

Article

Ultra-fast whole-body bone tomoscintigraphies achieved with a high-sensitivity 360° CZT camera and a dedicated deep-learning noise reduction algorithm.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1215, doi. 10.1007/s00259-023-06558-w

By:

Bahloul, Achraf;
Verger, Antoine;
Lamash, Yechiel;
Roth, Nathaniel;
Dari, Diawad;
Marie, Pierre-Yves;
Imbert, Laetitia

Publication type:

Article

[18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1297, doi. 10.1007/s00259-023-06557-x

By:

Allard, Bastien;
Devauchelle-Pensec, Valérie;
Saraux, Alain;
Nowak, Emmanuel;
Tison, Alice;
Boukhlal, Sara;
Guellec, Dewi;
Jousse-Joulin, Sandrine;
Cornec, Divi;
Marhadour, Thierry;
Le Pennec, Romain;
Salaün, Pierre-Yves;
Querellou, Solène

Publication type:

Article

Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1467, doi. 10.1007/s00259-023-06556-y

By:

Akcay, Kaan;
Kibar, Ali;
Sahin, Onur Erdem;
Demirbilek, Muhammet;
Beydagi, Gamze;
Asa, Sertac;
Aghazada, Fuad;
Toklu, Turkay;
Selcuk, Nalan Alan;
Onal, Bulent;
Kabasakal, Levent

Publication type:

Article

A convolutional neural network–based system for fully automatic segmentation of whole-body [68Ga]Ga-PSMA PET images in prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1476, doi. 10.1007/s00259-023-06555-z

By:

Jafari, Esmail;
Zarei, Amin;
Dadgar, Habibollah;
Keshavarz, Ahmad;
Manafi-Farid, Reyhaneh;
Rostami, Habib;
Assadi, Majid

Publication type:

Article

Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1371, doi. 10.1007/s00259-023-06526-4

By:

Liu, Guobing;
Shi, Yimeng;
Hou, Xiaoguang;
Yu, Haojun;
Hu, Yan;
Zhang, Yiqiu;
Shi, Hongcheng

Publication type:

Article

Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1361, doi. 10.1007/s00259-023-06554-0

By:

Voltin, Conrad-Amadeus;
Paccagnella, Andrea;
Winkelmann, Michael;
Heger, Jan-Michel;
Casadei, Beatrice;
Beckmann, Laura;
Herrmann, Ken;
Dekorsy, Franziska J.;
Kutsch, Nadine;
Borchmann, Peter;
Fanti, Stefano;
Kunz, Wolfgang G.;
Subklewe, Marion;
Kobe, Carsten;
Zinzani, Pier Luigi;
Stelljes, Matthias;
Roth, Katrin S.;
Drzezga, Alexander;
Noppeney, Richard;
Rahbar, Kambiz

Publication type:

Article

Comparative assessment of radiation therapy–induced vasculitis using [18F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1444, doi. 10.1007/s00259-023-06535-3

By:

Evanson, D.;
Griffin, M.;
O'Reilly, S. E.;
Johnson, T.;
Werner, T.;
Kothekar, E.;
Jahangiri, P.;
Simone 2nd, C. B.;
Swisher-McClure, S.;
Feigenberg, S. J.;
Revheim, M.-E.;
Zou, J.;
Alavi, A.

Publication type:

Article

The EANM Focus 5 consensus on 'molecular imaging and theranostics in prostate cancer': the future begins today.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1462, doi. 10.1007/s00259-023-06552-2

By:

Oprea-Lager, Daniela-Elena;
MacLennan, Steven;
Dierckx, Rudi;
Fanti, Stefano

Publication type:

Article

First-in-human SPECT/CT imaging of [212Pb]Pb-VMT-α-NET in a patient with metastatic neuroendocrine tumor.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1490, doi. 10.1007/s00259-023-06529-1

By:

Michler, Enrico;
Kästner, David;
Brogsitter, Claudia;
Pretze, Marc;
Hartmann, Holger;
Freudenberg, Robert;
Schultz, Michael K.;
Kotzerke, Jörg

Publication type:

Article

Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma—a proof of concept study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1409, doi. 10.1007/s00259-023-06528-2

By:

Liatsou, Ioanna;
Fu, Yingli;
Li, Zhi;
Hasan, Mahmud;
Guo, Xin;
Yu, Jing;
Piccolo, Joseph;
Cartee, Allison;
Wang, Hao;
Du, Yong;
Bryan, Jeffrey;
Gabrielson, Kathleen;
Kraitchman, Dara L.;
Sgouros, George

Publication type:

Article

FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1287, doi. 10.1007/s00259-023-06548-y

By:

Liu, Bonnia;
Ma, Ronald;
Shum, Evonne;
Hormiz, Maria;
Lee, Sze-Ting;
Poon, Aurora M. T.;
Scott, Andrew M.

Publication type:

Article

Adhesion molecule–targeted magnetic particle imaging nanoprobe for visualization of inflammation in acute lung injury.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1233, doi. 10.1007/s00259-023-06550-4

By:

Gao, Pengli;
Liu, Yu;
Wang, Xiaoli;
Feng, Xin;
Liu, Heng;
Liu, Songlu;
Huang, Xiazi;
Wu, Xiangjun;
Xiong, Fei;
Jia, Xiaohua;
Hui, Hui;
Jiang, Jingying;
Tian, Jie

Publication type:

Article

CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1383, doi. 10.1007/s00259-023-06547-z

By:

Dreher, Niklas;
Hahner, Stefanie;
Fuß, Carmina T.;
Schlötelburg, Wiebke;
Hartrampf, Philipp E.;
Serfling, Sebastian E.;
Schirbel, Andreas;
Samnick, Samuel;
Higuchi, Takahiro;
Weich, Alexander;
Lapa, Constantin;
Rosenwald, Andreas;
Buck, Andreas K.;
Kircher, Stefan;
Werner, Rudolf A.

Publication type:

Article

Detection of metabolic adaptation in a triple-negative breast cancer animal model with [18F]choline-PET imaging as a surrogate for drug resistance.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1261, doi. 10.1007/s00259-023-06546-0

By:

Kohan, Andres A.;
Lupien, Mathieu;
Cescon, David;
Deblois, Geneviève;
Ventura, Manuela;
Metser, Ur;
Veit-Haibach, Patrick

Publication type:

Article

Performance of [18F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1349, doi. 10.1007/s00259-023-06537-1

By:

Boucher, Aymeric;
Delabie, Julia;
Lussey-Lepoutre, Charlotte;
Haissaguerre, Magalie;
Ouvrard, Eric;
Lavinia, Vija;
Le Bras, Maëlle;
Batisse-Lignier, Marie;
Cuny, Thomas;
Jacquet-Francillon, Nicolas;
Gaujoux, Sébastien;
Molina, Océane;
Imperiale, Alessio;
Latge, Adrien;
Ansquer, Catherine;
Kelly, Antony;
Borson-Chazot, Françoise;
Tlili, Ghoufrane;
Sebag, Frédéric;
Hamidou, Zeinab

Publication type:

Article

High-temporal resolution functional PET/MRI reveals coupling between human metabolic and hemodynamic brain response.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1310, doi. 10.1007/s00259-023-06542-4

By:

Hahn, Andreas;
Reed, Murray B.;
Vraka, Chrysoula;
Godbersen, Godber M.;
Klug, Sebastian;
Komorowski, Arkadiusz;
Falb, Pia;
Nics, Lukas;
Traub-Weidinger, Tatjana;
Hacker, Marcus;
Lanzenberger, Rupert

Publication type:

Article

The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1436, doi. 10.1007/s00259-023-06516-6

By:

Mei, Riccardo;
Pyka, Thomas;
Sari, Hasan;
Fanti, Stefano;
Afshar-Oromieh, Ali;
Giger, Roland;
Caobelli, Federico;
Rominger, Axel;
Alberts, Ian

Publication type:

Article

Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1451, doi. 10.1007/s00259-023-06513-9

By:

Jannusch, Kai;
Dietzel, Frederic;
Bruckmann, Nils Martin;
Morawitz, Janna;
Boschheidgen, Matthias;
Minko, Peter;
Bittner, Ann-Kathrin;
Mohrmann, Svjetlana;
Quick, Harald H.;
Herrmann, Ken;
Umutlu, Lale;
Antoch, Gerald;
Rubbert, Christian;
Kirchner, Julian;
Caspers, Julian

Publication type:

Article

Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1488, doi. 10.1007/s00259-023-06511-x

By:

Glantschnig, Lisa;
Dierks, Alexander;
Wienand, Georgine;
Pfob, Christian H.;
Bundschuh, Ralph A.;
Lapa, Constantin;
Kircher, Malte

Publication type:

Article

Works in European Journal of Nuclear Medicine & Molecular Imaging, 2024, Vol 51, Issue 5

Advances in targeted alpha therapy of cancer.

Letter to the Editor: FDG Liver Biodistribution.

Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance.

EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.

A. Zaheer, S.P. Raman, M.L. Rosado-de-Christenson, S. Martínez-Jiménez, S.H. Garrana, G. Fananapazir, D. Rogers, B.R. Foster: Imaging Anatomy: Chest, Abdomen, Pelvis, 3rd Edition: Elsevier, 2024, ISBN 9780443118005.

Impact of patient motion on parametric PET imaging.

Beyond stillness: the importance of tackling patient's motion for reliable parametric imaging.

Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges.

Correction to: Theranostic role of <sup>89</sup>Zr‑ and <sup>177</sup>Lu‑labeled aflibercept in breast cancer.

After one year of ChatGPT's launch: reflections on artificial intelligence in scientific writing.

Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive l-[methyl-11C] methionine cohort study with two PET scanners.

Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration-resistant prostate cancer.

Expanding the clinical indications of [<sup>18</sup>F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded.

Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance.

Effects of medication on dopamine transporter imaging using [<sup>123</sup>I]I-FP-CIT SPECT in routine practice.

Theranostic role of <sup>89</sup>Zr- and <sup>177</sup>Lu-labeled aflibercept in breast cancer.

[<sup>177</sup>Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models.

Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy.

Ultra-fast whole-body bone tomoscintigraphies achieved with a high-sensitivity 360° CZT camera and a dedicated deep-learning noise reduction algorithm.

[<sup>18</sup>F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica.

Prediction of clinically significant prostate cancer by [<sup>68</sup> Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.

A convolutional neural network–based system for fully automatic segmentation of whole-body [<sup>68</sup>Ga]Ga-PSMA PET images in prostate cancer.

Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [<sup>18</sup>F]FDG tumor kinetic metrics.

Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.

Comparative assessment of radiation therapy–induced vasculitis using [<sup>18</sup>F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy.

The EANM Focus 5 consensus on 'molecular imaging and theranostics in prostate cancer': the future begins today.

First-in-human SPECT/CT imaging of [<sup>212</sup>Pb]Pb-VMT-α-NET in a patient with metastatic neuroendocrine tumor.

Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma—a proof of concept study.

FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis.

Adhesion molecule–targeted magnetic particle imaging nanoprobe for visualization of inflammation in acute lung injury.

CXCR4-directed PET/CT with [<sup>68</sup> Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology.

Detection of metabolic adaptation in a triple-negative breast cancer animal model with [<sup>18</sup>F]choline-PET imaging as a surrogate for drug resistance.

Performance of [<sup>18</sup>F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease.

High-temporal resolution functional PET/MRI reveals coupling between human metabolic and hemodynamic brain response.

The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation.

Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [<sup>18</sup>F]FDG-PET/MRI.

Intense PSMA expression of the uvula detected by [<sup>68</sup> Ga]Ga-PSMA-PET/CT.